JFG
LAB icon

Jefferies Financial Group’s Standard BioTools LAB Stock Holding History

Jefferies Financial Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-119,400
Closed -$324K – 1654
2024
Q1 		$324K Buy
119,400
+63,000
+112% +$152K ﹤0.01% 1188
2023
Q4 		$125K Hold
56,400
– – ﹤0.01% 1522
2023
Q3 		$164K Buy
+56,400
New +$148K ﹤0.01% 1380

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Jefferies Financial Group's LAB Position: Q2 2024 in Review

Jefferies Financial Group sold out of Standard BioTools (LAB) in Q2 2024, closing a stake of 119,400 shares — an estimated $324K sold.

Jefferies Financial Group first reported a position in LAB in Q3 2023 and held it in 3 quarters. The position peaked at $324K in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2024.

  • Jefferies Financial Group reported no remaining Standard BioTools position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 119,400 Standard BioTools shares in Q2 2024, an estimated $324K.
  • Jefferies Financial Group first reported a position in Standard BioTools in Q3 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Standard BioTools position peaked at $324K in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.